Arch Therapeutics, Inc.
ARTHDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001537561
Arch Therapeutics, Inc. was delisted in 2022; its insiders filed their last Form 4 on Sep 8, 2023; 1 institution reported holding it in 13F filings for Q3 2022, worth $0 in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Arch Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 4 | 3 | −1 |
| Shares | 136.0K | 81.0K | −55.0K (−40.4%) |
| Value | $12.0K | $10.0K | −$2.00K (−16.7%) |
New holders (0)
Institutions that held Arch Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (1)
Institutions that held Arch Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Chelsea Counsel Co | 55,000 | $5.00K |